Navigation Links
Hepatitis C treatment is cost-effective for the US prison population
Date:10/20/2008

Treating all U.S. prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (www.interscience.wiley.com).

U.S. prisons incarcerate more than 2 million inmates each year, and between 12 and 31 percent of them are infected with chronic hepatitis C (HCV), mostly related to high rates of intravenous drug use. The current standard treatment for HCV has been shown to be cost-effective in the general population and the Federal Bureau of Prisons recommends HCV treatment for those who meet the AASLD's criteria for treatment, as long as therapy is likely to be completed. However, each state adopts its own set of treatment guidelines, and many prisoners do not ultimately get treated.

Proponents for treatment argue that we have an ethical duty to provide prisoners with the best medical practices available, and treating HCV could reduce new infections as well as future medical expenses from advanced liver disease. Opponents point out that treatment is expensive and must be paid for by taxpayers, while many non-imprisoned HCV patients who don't have health insurance are denied access to this care.

Researchers, led by Sammy Saab of the David Geffen School of Medicine at UCLA, sought to determine if HCV treatment would be cost-effective in the male prison population (men make up over 87 percent of U.S. prisoners). They examined published literature for relevant studies and constructed a decision analysis model employing Markov simulation, using the generally accepted cost-effectiveness threshold of $50,000 per quality-adjusted life years.

"Our model found that treatment was cost-saving for prison
'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
2. Majority of children vaccinated against hepatitis B not at increased risk of MS
3. How to select anti-hepatitis B virus agents for drug-resistance patients?
4. The prevalence of hepatitis B virus infection in inflammatory bowel disease patients
5. A potential approach to treatment of hepatitis B virus infection
6. New approach, old drug show promise against hepatitis C, Stanford research shows
7. Early treatment is key to combating hepatitis C virus
8. New treatment therapy helps inhibit hepatitis C
9. Liver damage in hepatitis C patients could be treated with warfarin, says study
10. Study Disproves Belief That Hepatitis C Blunts HIV Drugs
11. Hepatitis B Foundation Sponsors Two-Day Educational Conference for Children and Adults at Risk for Deadly Liver Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... OH (PRWEB) May 22, 2015 River ... that Kyle Johnson, the health system’s Chief Financial Officer ... interests. Johnson has served as the company CFO since ... West will be joining the health system as CFO. ... an interim basis, while the Board of Trustees conducts ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2
... from the Children,s Cancer Hospital at The University of Texas ... to more accurately predict treatment outcomes in young leukemia patients ... test, also known as a CBC. The results ... of Pediatric Hematology Oncology,s (ASPHO) annual meeting today. The study ...
... or friends, survey finds , FRIDAY, April 9 (HealthDay News) ... most likely to sexually abuse children when, in fact, relatives ... By doing so, parents may be failing to give their ... it happens and try to stop it, the study authors ...
... ... the issue of “medication adherence.” , ... Alexandria, VA (Vocus) April 10, 2010 -- An article in the ... the National Association of Chain Drug Stores’ (NACDS) message that pharmacy’s role in helping ...
... in the United States has experienced a conflict with ... patient care, researchers from the University of Chicago report ... Journal of General Internal Medicine . Younger and ... conflicts than their older or more religious peers. Most ...
... early recover faster, reduce sedative use, research shows , FRIDAY, ... intensive care unit may reduce their use of sedatives and ... study has found. , The amount of prescription sedatives had ... which reduced the amount of muscle weakness caused by spending ...
... ... Equals a Charitable Donation to Further the Safe Handling of Hazardous Drugs , ... COLUMBUS, OH (Vocus) April ... “Safe Handling Dance”? In recognition of National Safe Handling Awareness Month (April), Carmel Pharma, ...
Cached Medicine News:Health News:M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients 2Health News:Kids Often Misled About Child Abuse 2Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 2Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 3Health News:Primary care physicians nationwide face clinical ethical conflicts with religious hospitals 2Health News:Mild Exercise Good for the Critically Ill 2Health News:Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations 2Health News:Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations 3Health News:Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations 4Health News:Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations 5
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... appreciative of all the hard work that the Minister and ... six months. This program recognizes the needs of the thalidomide ... least $75,000 a year, tax free, with annual adjustments for ... eligible for annual payments of $100,000 based on the severity ...
(Date:5/22/2015)... Solutions, Inc. (NASDAQ: BLFS ), a leading developer, manufacturer ... and cryopreservation freeze media and precision thermal ... "Company"), announced that the Company is scheduled to present at ... is scheduled to present at the Conference at 1:30 p.m. ... Hotel in New York City and ...
(Date:5/22/2015)... -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development ... announced that J.J. Finkelstein , chief executive officer ... at two upcoming investor conferences. Mr. ... Annual Microcap Conference on Thursday May 28, 2015 in ... am EDT.  A webcast will be available at the ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... Dear President-Elect Obama:, , ... billions of dollars,earmarked for stem cell research. As spokesman ... of the Repair Stem Cell research and,treatment industry worldwide, I ... our industry and the medical and scientific professionals,hospitals, treatment centers ...
... Tenn., Nov. 24 A new cancer treatment ... weeks,of treatment, a patient,s large, stage 4 tumor ... weeks of treatment, it no longer could be ... six to nine months,after diagnosis. NeoPlas Innovation,s combination ...
Cached Medicine Technology:Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute 2New Cancer Treatment Shrinks Pancreatic Tumor 2
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
... Utilizing technology developed over Guidants 20-year ... the new foundation for successful treatment outcomes. ... tip design with a lower profile shaft,more ... Now you can cross tight and tortuous ...
Test for AFP...
Test for AFP...
Medicine Products: